Olink Holding AB Stock

Equities

OLK

US6807101000

Office Equipment

Market Closed - Nasdaq 16:00:00 2024-04-26 EDT 5-day change 1st Jan Change
22.84 USD -1.00% Intraday chart for Olink Holding AB +4.44% -9.18%
Sales 2024 * 206M 282M Sales 2025 * 272M 371M Capitalization 2.84B 3.88B
Net income 2024 * -18M -24.6M Net income 2025 * 12M 16.4M EV / Sales 2024 * 13.2 x
Net cash position 2024 * 115M 157M Net cash position 2025 * 133M 182M EV / Sales 2025 * 9.96 x
P/E ratio 2024 *
-149 x
P/E ratio 2025 *
228 x
Employees 707
Yield 2024 *
-
Yield 2025 *
-
Free-Float 15.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.00%
1 week+4.44%
Current month-2.85%
1 month-5.07%
3 months-9.00%
6 months-7.90%
Current year-9.18%
More quotes
1 week
21.82
Extreme 21.82
23.24
1 month
21.80
Extreme 21.8
23.78
Current year
21.68
Extreme 21.68
25.20
1 year
14.10
Extreme 14.1
26.01
3 years
8.39
Extreme 8.39
40.36
5 years
8.39
Extreme 8.39
42.20
10 years
8.39
Extreme 8.39
42.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 20-11-30
President 53 20-07-31
Director of Finance/CFO 39 20-02-29
Members of the board TitleAgeSince
Director/Board Member 66 17-12-31
Chairman 68 20-12-31
Chief Executive Officer 57 20-11-30
More insiders
Date Price Change Volume
24-04-26 22.84 -1.00% 78,698
24-04-25 23.07 +2.85% 295,186
24-04-24 22.43 +1.04% 244,287
24-04-23 22.2 +0.77% 314,619
24-04-22 22.03 +0.73% 334,135

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm

More quotes
Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
22.84 USD
Average target price
26 USD
Spread / Average Target
+13.84%
Consensus